Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 μg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis

This publication has 22 references indexed in Scilit:

• The Case-Case-Control Study Design: Addressing the Limitations of Risk Factor Studies for Antimicrobial Resistance
  Infection Control & Hospital Epidemiology, 2005
• Costs and Outcomes Among Hemodialysis-Dependent Patients With Methicillin-Resistant or Methicillin-SusceptibleStaphylococcus aureusBacteremia
  Infection Control & Hospital Epidemiology, 2005
• National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004
  American Journal of Infection Control, 2004
• Special Article: National Surveillance of Dialysis‐Associated Diseases in the United States, 2001
  Seminars in Dialysis, 2004
• Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
  Journal of Clinical Microbiology, 2004
• Infection with Vancomycin-ResistantStaphylococcus aureusContaining thevanAResistance Gene
  New England Journal of Medicine, 2003
• Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusBacteremia: A Meta‐analysis
  Clinical Infectious Diseases, 2003
• Validation of Vitek version 7.01 software for testing staphylococci against vancomycin
  Diagnostic Microbiology and Infectious Disease, 2002
• In Vitro Activities of Daptomycin, Vancomycin, Linezolid, and Quinupristin-Dalfopristin against Staphylococci and Enterococci, Including Vancomycin- Intermediate and -Resistant Strains
  Antimicrobial Agents and Chemotherapy, 2000
• Slow Response to Vancomycin or Vancomycin plus Rifampin in Methicillin-resistant Staphylococcus aureus Endocarditis
  Annals of Internal Medicine, 1991